small default large print mail

Research

Axel Schonthal
Axel Schönthal, PhD, Univ. of Southern California Keck School of Medicine

National Brain Tumor Society research programs play an integral role in the progress toward new therapies for brain tumor patients. We fund investigations that seek new targets to improve existing therapeutic options, which will ultimately lead to a cure.

NBTS funds research that meets our dual criteria: promising scientific potential to lead to successful clinical trials, as well as the planning and commitment to see that science through the logistical steps of the research and development pipeline.

Finding, Funding and Following Transformative Progress

 
National Brain Tumor Society believes that potentially-transformative research must be supported by informed private funders. Public research funding is essential for basic and early translational research, but there are systemic challenges to scientists who have the potential to make progress in leaps and bounds, rather than incremental steps.

Academic institutions and individual researchers contribute essential findings to the brain tumor field. National Brain Tumor Society is committed to moving this critical knowledge beyond the bench by connecting it to industry partners. Biotechnology and pharmaceutical companies have the motivation, expertise and resources to drive promising science into clinical trials - and beyond, to the brain tumor patients who need more effective therapies to improve quality of life.

With our visionary board leadership and professional staff expertise, the National Brain Tumor Society established a three-tiered funding structure to both affect and direct promising research.

New Priorities for Pediatric Brain Tumor Research

 
National Brain Tumor Society has always funded investigations for both adult and pediatric tumor types. Across the field, there remains a substantial difference in scientific knowledge between adult and pediatric tumors. Now, our Pediatric Research Initiative prioritizes the areas of research that we believe will close this knowledge gap and lead to swifter progress in future pediatric research.

Learn more about: